国際招待講演（２０１２年）

  1. Horie Y. Genetics of VKH disease. Symposium; The role of genetics in uveitis and ocular inflammation. 27th Asia-Pacific Academy of Ophthalmology (APAO): Busan, Korea; 2012/4/15
  2. Ishida S. Changes in retinal layer thickness after vitrectomy for macular diseases. The Chinese University of Hong Kong Ophthalmology Forum 2012 and Hong Kong Eye Hospital 20th Anniversary Symposium: Hong Kong, China; 2012/12/16
  3. Ishida S. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Symposium; Cellular and molecular investigations in viteroretinal diseases. The 8th International Symposium of Ophthalmology-Hong Kong: Hong Kong, China; 2012/12/15
  4. Ishida S. Molecular pathogenesis of retinal neovascualrization and inflammation　in diabetic retinopathy. Symposium; Advances in the management of diabetic retinopathy. The 8th International Symposium of Ophthalmology-Hong Kong: Hong Kong, China; 2012/12/14
  5. Ishida S. Retinal outer layer thickness increases after vitrectomy for epiretinal membrane and macular hole. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  6. Ishida S. Changes in retinal layer thickness after vitrectomy for macular diseases. Retina Symposium Ⅱ; Tips in vitreoretinal surgery. 53rd Annual Meeting of the Ophthalmological Society of Taiwan / 15th Taipei International Symposium of Ophthalmology: Taipei, Taiwan; 2012/11/18
  7. Ishida S. Bioactibity of VEGF family receptors: To better understand a new VEGF blocker. Retina SymposiumⅠ; Anti-VEGF. 53rd Annual Meeting of the Ophthalmological Society of Taiwan / 15th Taipei International Symposium of Ophthalmology: Taipei, Taiwan; 2012/11/18
  8. Ishida S. The relationship between VEGF and renin-angiotensin system in human diabetic retinopathy. Symposium; How it responds to aging and diseases. 108th Annual Meeting of the Korean Ophthalmological Society: Seoul, Korea; 2012/11/3
  9. Ishida S. VEGF biology and anti-VEGF therapy. wAMD Expert Meeting in ARVO 2012: Fort Lauderdale, USA; 2012/5/6
  10. Ishida S. Molecular mechanisms in antioxidant-induced suppression of choroidal neovascularization. Symposium; Anti-oxidation and anti-angiogenesis. 27th Asia-Pacific Academy of Ophthalmology (APAO): Busan, Korea; 2012/4/16
  11. Ishida S. Contributions of opthalmologists to the earthquake / tsunami survivors in Japan. Project presentatin 1; Public health. 27th Asia-Pacific Academy of Ophthalmology (APAO): Busan, Korea; 2012/4/16
  12. Kanda A. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.2012 Seoul National University-Hokkaido Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  13. Kase S. Clinical features of human T lymphotropic virus type-1 associated uveitis in Hokkaido, Japan. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  14. Kitaichi N. Inhibition of toxic advanced glycation endoproducts formation ameliorates experimental autoimmune uveoretinitis in mice. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  15. Kitaichi N. Characteristics and complications of endogenous uveitis in Japan. Seminar on Ocular Signs and Systemic Diseases in Sapporo: Sapporo; 2012/7/11
  16. Kitaichi N. Adaliumumab for ocular inflammatory diseases; First Biologic Approved for Uveitis? Symposium; Therapies in development for uveitis: What are coming to the clinics? 27th Asia-Pacific Academy of Ophthalmology (APAO): Busan, Korea; 2012/4/15
  17. Kitaichi N. Uveitis in Japan. Symposium; Epidemiology of uveitis in Asai-Pacific region. 27th Asia-Pacific Academy of Ophthalmology (APAO): Busan, Korea; 2012/4/14
  18. Kitaichi N. Epidemiology of uveitis and related intraocular inflammations in Japan. Epidemiology of uveitis and related intraocular inflammations. World Ophthalmology Congress (WOC): Abu Dhabi, United Arab Emirates; 2012/2/17
  19. Lennikov A. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  20. Namba K. Novel scoring system of ocular lesions in Behcet’s disease; BOS24. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  21. Namba K, Kaburaki T, Sonoda KH, Ohno S, Ocular Behcet’s Disease Research Group of Japan. Novel scoring system of ocular lesions in Behcet´s disease. 8th International Symposium on Uveitis: Sani Beach, Greece; 2012/10/19
  22. Namba K. Vitrectomy for non-infectious uveitis. Symposium; Surgical interventions in the diagnosis and management of recalcitrant uveitis. 27th Asia-Pacific Academy of Ophthalmology (APAO): Busan, Korea; 2012/4/15
  23. Noda K. Recent advances in understanding the molecular mechanism of diabetic retinopathy. Symposium; Diabetic vascular complications. The 10th Korea-Japan Joint Symposium on Vascular Biology: Tokushima, Japan; 2012/12/6
  24. Noda K. Soluble vascular adhesion protein-1 in proliferative diabetic retinopathy. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  25. Noda K. Combination therapy for AMD in Hokkaido. wAMD Expert Meeting in ARVO 2012: Fort Lauderdale, USA; 2012/5/6
  26. Ohno S, Chin S. Management dilemmas in uveitis. Second Biennial National Conference, Bangladesh Uvea Society: Dhaka, Bangladesh; 2012/12/15
  27. Ohno S. Presentation perspectives in Vogt-Koyanagi-Harada disease. Bangladesh Uvea Society: Dhaka, Bangladesh; 2012/12/15
  28. Ohno S. Corticosteroid therapy in uveitis. Ophthalmology Seminar, Thimpu National Referral Hospital: Thimpu, Bhutan; 2012/12/12
  29. Ohno S, Chin S. Management of secondry glaucoma in uveitis. Ophthalmology Seminar, Thimpu National Referral Hospital: Thimpu, Bhutan; 2012/12/12
  30. Ohno S. Dry eye disorders and ocular allergy. 1st Indo-China Intraocular Inflammation / Uveitis Meeting: Siem Reap, Cambodia; 2012/12/7
  31. Ohno S. From autoimmunity to autoinflammation in the immunopathogenesis of Behcet’s disease. 2012 Seoul National University-Hokkaido University Joint Symposium in Ophthalmology: Sapporo, Japan; 2012/11/19
  32. Ohno S. Epidemiology and genetics of Behcet’s disease. Bechet’s Disease Symposium; How to differentiate Behcet’s disease from other types of uveitis. 8th International Symposium on Uveitis: Sani Beach Greece; 2012/10/19
  33. Ohno S. Silk route disease: epidemiology and genetics. International meeting of collaborative studies on Behcet’s disease and other uveitis entities: Rome, Italy; 2012/10/16
  34. Ohno S. Anti-TNFα therapy for intractable uveoretinitis in Behcet’s disease. 15th International Conference on Behcet’s Disease: Yokohama, Japan; 2012/7/14
  35. Ohno S. Diagnosis and treatment of allergic conjuctivitis.16th Afro Asian Congress of Ophthalmology: Istanabul, Turkey; 2012/6/15
  36. Ohno S. Ocular lesions in Behcet’s disease.16th Afro Asian Congress of Ophthalmology: Istanabul, Turkey; 2012/6/13
  37. Ohno S. Epidemiology of allergic conjunctival diseases in Japan. 1st Conference on the Tear Film and Ocular Surface in Asia: Kamakura, Japan; 2012/4/4
  38. Ohno S. Behcet’s disease. Genetics of ocular inflammatory disorders. World Ophthalmology Congress (WOC): Abu Dhabi, United Arab Emirates; 2012/2/18
  39. Ohno S. Behcet’s disease. Prevention of blindness due to infectious and inflammatory ocular diseases. ICO Lecture: G.O.H. Naumann Award for Leadership and Global Eye Care for 2012. World Ophthalmology Congress (WOC): Abu Dhabi, United Arab Emirates; 2012/2/15
  40. Yoshizawa C. Case presentation and discussion; Focusing on the persistent cases of AMD in clinical practice. AMD Subspecialty Sunday in Hokkaido: Sapporo, Japan; 2012/5/27